Skip to main content
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · SNOA ISIN · US83558L2043 US Manufacturing
Open in API
Filings indexed 951 across all filing types
Latest filing 2011-06-02 Regulatory Filings
Country US United States of America
Listing US SNOA

About Sonoma Pharmaceuticals, Inc.

https://sonomapharma.com/

Sonoma Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and commercializes products based on its patented Microcyn® Technology, a stabilized hypochlorous acid (HOCl) platform. With over 20 years of experience, the company produces a range of prescription and over-the-counter solutions for advanced wound care, dermatology, animal health, and eye care. Its products are designed to manage various conditions by promoting healing and reducing the risk of infection. The portfolio serves healthcare professionals in settings like hospitals and nursing homes, as well as consumers for at-home use.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text specifically mentions that the company issued a press release announcing financial results for its fiscal quarter and fiscal year ended March 31, 2011, and that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or comprehensive financial analysis but rather announces the results and provides the press release. The document length is 4150 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of financial results, not the full earnings release or annual report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit the other specific categories like 10-K or ER (Earnings Release) which require substantive financial data within the document itself.
2011-06-02 English
Capital/Financing Update 2011
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to the issuance of common stock shares. It includes detailed information about the offering, risk factors, company background, and use of proceeds. The document is not a financial report, earnings release, or management discussion but rather a capital raising disclosure document. The presence of terms like 'Prospectus Supplement', 'Registration No.', 'Rule 424(b)(5)', and detailed offering information indicates this is a Capital/Financing Update filing. The document length is substantial and contains the full prospectus supplement text, not just an announcement or link to a report, confirming it is the actual filing of the financing document.
2011-05-20 English
Regulatory Filings 2011
Regulatory Filings
2011-05-04 English
Regulatory Filings 2011
Regulatory Filings Classification · 80% confidence The document text appears to be encoded or corrupted and does not contain any readable content or keywords related to specific financial filings. There are no references to regulatory bodies, report titles, fiscal periods, or any other indicators that would allow classification into a specific filing category. The document length is 9209 characters, which is substantial, but the content is not interpretable. Given the lack of meaningful content, the best classification is Regulatory Filings (RNS), which serves as a fallback category for miscellaneous or unclear filings.
2011-05-04 English
Regulatory Filings 2011
Regulatory Filings
2011-05-04 English
Regulatory Filings 2011
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-3. It is a correspondence related to a regulatory filing process, specifically about the timing of a registration statement becoming effective. The document does not contain financial data, audit information, or detailed report content. It is a regulatory communication rather than a report or announcement of financial results. Given the short length (1669 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory communications that do not fit other specific categories.
2011-05-02 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.